Latest pharmaceutical industry Stories
Development planned for multiple autoimmune diseases, including rheumatoid arthritis and lupus INDIANAPOLIS, March 19, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Hanmi
- Total Revenue Increased 51% in 2014 - IRVINE, Calif., March 19, 2015 /PRNewswire/ -- ChromaDex Corp.
SEATTLE and BERKELEY, Calif.
In the wake of the Food and Drug Administration’s first approval for a biosimilar product, pharma industry experts offer advice on how payers can prepare for this new class of drugs in the March
DALLAS, March 18, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Hepatitis C - Pipeline Review, H1 2015" therapeutic market research report of 639 pages with latest updates,
LONDON, March 18, 2015 /PRNewswire/ -- Report Details Medicine sales in Brazil- your guide to trends, opportunities and revenue prospects Do you want to assess
IDE approval follows recent CE Mark approval, with initial EU/Asia Pacific commercialization to begin in 2015 MOUNTAIN VIEW, Calif., March 18, 2015 /PRNewswire/ -- Simplify Medical,
-- Lexicon eligible for an additional $5 million in up-front and pre-commercial milestone payments for Canadian rights, plus royalties and sales milestones under original agreement --
MENLO PARK, Calif., March 18, 2015 /PRNewswire/ -- BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address
MACCLESFIELD, England, March 18, 2015 /PRNewswire/ -- UK based Gentronix Limited, the specialist genetic toxicology company, today announced it has signed a three year
- Large; stout; burly.